close

Fundraisings and IPOs

1 2 3 4 5 73
Number of results: 1449
Date Company Amount Funding type Investors Therapeutic area Type of Information
2018-05-23 Celyad (Belgium) $54.4 million (approximately €46.1 million), private placement Cancer - Oncology Private placement
2018-05-16 HiFiBiO Therapeutics (USA - MA) $37.5 million series B financing round Sequoia China (China) LYFE Capital (China) VI Ventures (China) Nest.Bio Ventures (USA - MA) Legend Star Capital (China) Proxima Ventures (Israel) Technology - Services Series B financing round
2018-05-09 IGEM Therapeutics (UK) £1.45 million grant Innovate UK (UK) Cancer - Oncology Grant
2018-05-08 InflaRX (Germany) $62.9 million private placement Inflammatory diseases Private placement
2018-05-07 Melinta Therapeutics (USA - CT) up to $6.2 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2018-05-03 Synpromics (UK) £1.9 million grant Scottish Enterprise (UK) Technology - Services Grant
2018-04-30 Sangamo Therapeutics (USA - CA) $230 million private placement Rare diseases - Genetic diseases Private placement
2018-04-27 Sangamo Therapeutics (USA - CA) $8 million grant California Institute for Regenerative Medicine (CIRM) (USA - CA) Rare diseases - Genetic diseases - Hematological diseases Grant
2018-04-27 A-Mansia (Belgium) €13 million series A financing round Seventure (France) Fonds Vives II (Belgium) SRIW Life Sciences (Belgium) Nivelinvest (Belgium) Pierre Drion Metabolic diseases Series A financing round
2018-04-26 Mereo BioPharma (UK) IPO Rare diseases - Genetic diseases IPO
2018-04-19 Tmunity Therapeutics (USA - PA) $135 million series A financing round Kleiner Perkins (USA) Ping An Ventures (China) Parker Institute for Cancer Immunotherapy (USA - CA) Gilead Sciences, (USA - CA) Be The Match BioTherapies (USA - MN) University of Pennsylvania (USA - PA) Lilly Asia Ventures (China) Cancer - Oncology Series A financing round
2018-04-02 ITBMed (Sweden) up to $67 million financing round Royalty Pharma (US - NY) Transplantation Financing round
2018-03-27 Poietis (France) €5 million series A financing round, grant WiSEED (France) Nouvelle Aquitaine Coinvestment Fund (France) Technology - Services Series A financing round
2018-03-15 Ideaya Bioscience (USA - CA) $94 million series B financing round BVF Partners (USA - CA) Perceptive Advisors (USA - NY) 6 Dimensions Capital (China) Tavistock Group (Bahamas) Nextech Invest (Switzerland) GV (USA - CA) Roche Venture Fund (Switzerland) 5AM Ventures (USA - CA) Canaan Partners (USA - CA) Celgene (USA - NJ) WuXi Healthcare Ventures (China) Novartis Institute of Biomedical Research -Alexandria Real Estate Cancer - Oncology Series B financing round
2018-02-23 Fate Therapeutics (USA - CA) $4 million grant California Institute for Regenerative Medicine (CIRM) (USA - CA) Cancer - Oncology Grant
2018-02-23 Fate Therapeutics (USA - CA) $4 million grant California Institute for Regenerative Medicine (CIRM) (USA - CA) Cancer - Oncology Grant
2018-02-16 ABAC Therapeutics (Spain) €16 million series A financing round Pontifax (Israel) Quark Venture (Canada) GF Securities (China) Caixa Capital Risc (Spain) Debiopharm Innovation Fund (Switzerland) Ferrer (Spain) Infectious diseases Series A financing round
2018-02-07 Sangamo Therapeutics (USA - CA) Case Western Research University (USA - OH) $11 million grant National Institutes of Health (NIH) (USA) Infectious diseases Grant
2018-02-05 Metrion Biosciences (UK) £200 000 grant Innovate UK Biomedical Catalyst Feasibility Award scheme (UK) Autoimmune diseases - Neurodegenerative diseases Grant
2018-02-02 Viking Therapeutics (USA - PA) $55 million private placement Endocrinological diseases - Metabolic diseases Private placement